17206-Ovarian Cancer-NA-448

Ovarian Cancer

A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination with Pegylated Liposomal Doxorubicin or Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer (AVB500-OC-002)

  • Details

ClinicalTrials.gov ID: NCT03639246
Diagnosis Type: NA
USOR Number: 17206

  • Address

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.